Palvella Therapeutics, Inc. (NASDAQ:PVLA) showed up in the 13F filings of 180 institutional investors as of March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 1,153,496 | 261,096 | 29.26% | $143,783,276.00 |
| First Light Asset Management, LLC | 31 Mar, 2026 | 980,758 | 271,617 | 38.30% | $122,251,485.00 |
| BVF INC/IL | 31 Mar, 2026 | 960,989 | 81,980 | 9.33% | $119,787,279.00 |
| Frazier Life Sciences Management, L.P. | 31 Mar, 2026 | 882,400 | 160,000 | 22.15% | $109,991,160.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 686,853 | 127,788 | 22.86% | $85,616,227.00 |
| JENNISON ASSOCIATES LLC | 31 Mar, 2026 | 640,611 | 253,128 | 65.33% | $79,852,163.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 477,294 | 477,294 | 0.00% | $59,494,697.00 |
| State Street Corp | 31 Mar, 2026 | 458,999 | 38,537 | 9.17% | $57,214,225.00 |
| Federated Hermes, Inc. | 31 Mar, 2026 | 433,015 | 64,977 | 17.65% | $53,975,320.00 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 31 Mar, 2026 | 402,564 | 402,564 | 0.00% | $50,180.00 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 31 Mar, 2026 | 374,035 | 374,035 | 0.00% | $46,623,461.00 |
| Woodline Partners LP | 31 Mar, 2026 | 317,517 | 16,981 | 5.65% | $39,578,494.00 |
| ALLIANCEBERNSTEIN L.P. | 31 Mar, 2026 | 262,835 | -6,192 | -2.30% | $27,510,939.00 |
| Siren, L.L.C. | 31 Mar, 2026 | 257,485 | 182,485 | 243.31% | $32,095,505.00 |
| EVENTIDE ASSET MANAGEMENT, LLC | 31 Mar, 2026 | 233,248 | 131,500 | 129.24% | $29,049,685.00 |
| FMR LLC | 31 Mar, 2026 | 215,808 | -15,952 | -6.88% | $26,900,498.00 |
| MPM BioImpact LLC | 31 Mar, 2026 | 206,404 | 659 | 0.32% | $25,728,259.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 205,609 | 26,617 | 14.87% | $25,636,522.00 |
| PRIMECAP MANAGEMENT CO/CA/ | 31 Mar, 2026 | 195,030 | 195,030 | 0.00% | $24,310,490.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 194,179 | -3,691 | -1.87% | $24,204,412.00 |